Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AUTORISERET FYSIOTERAPEUT FUGLEGÅRDSVEJ FYSIOTERAPI ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6%   Bankruptcy risk   3.6% 2.9% 4.2% 4.2% 4.9% 4.6% 18.6% 11.9%   Credit score (0-100)   54 60 50 48 43 46 6 20   Credit rating   BBB BBB BBB BBB BBB BBB B BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,727 1,897 1,711 2,091 2,380 2,119 0.0 0.0   EBITDA   371 217 -117 169 22.3 209 0.0 0.0   EBIT   371 217 -118 160 -3.9 181 0.0 0.0   Pre-tax profit (PTP)   385.8 267.8 -80.6 88.6 -23.3 58.5 0.0 0.0   Net earnings   300.3 208.8 -64.1 70.4 -18.2 34.3 0.0 0.0   Pre-tax profit without non-rec. items   386 268 -80.6 88.6 -23.3 58.5 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Tangible assets total   0.0 0.0 24.5 113 103 75.0 0.0 0.0   Shareholders equity total   446 355 90.7 161 143 177 52.2 52.2   Interest-bearing liabilities   1,023 963 932 877 1,058 1,318 0.0 0.0   Balance sheet total (assets)   1,783 1,693 1,552 1,563 1,611 1,808 52.2 52.2   Net Debt   1,016 957 931 877 1,058 1,318 -52.2 -52.2     See the entire balance sheet 1000.0 Volume  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,727 1,897 1,711 2,091 2,380 2,119 0.0 0.0   Gross profit growth   215.3% 9.8% -9.8% 22.2% 13.8% -11.0% -100.0% 0.0%   Employees   0 0 4 4 5 4 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 25.0% -20.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,783 1,693 1,552 1,563 1,611 1,808 52 52   Balance sheet change%   423.4% -5.0% -8.3% 0.7% 3.1% 12.2% -97.1% 0.0%   Added value   370.5 217.0 -117.6 160.4 -3.9 181.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 24 80 -36 -55 -75 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 -1.0 1.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   21.5% 11.4% -6.9% 7.7% -0.2% 8.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   37.3% 16.9% -3.6% 10.3% 3.3% 12.7% 0.0% 0.0%   ROI %   49.1% 21.0% -5.0% 15.6% 4.7% 16.0% 0.0% 0.0%   ROE %   101.5% 52.1% -28.8% 55.9% -12.0% 21.4% 0.0% 0.0%   1000.0 Solidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Equity ratio %   25.0% 21.0% 5.8% 10.3% 8.9% 9.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   274.3% 441.2% -797.5% 519.5% 4,737.2% 630.6% 0.0% 0.0%   Gearing %   229.4% 271.5% 1,027.3% 544.5% 740.6% 744.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.1% 2.6% 2.3% 7.9% 7.9% 13.3% 0.0% 0.0%   1000.0 Liquidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Quick Ratio   1.2 1.2 1.0 0.9 0.9 1.0 0.0 0.0   Current Ratio   1.2 1.2 1.0 0.9 0.9 1.0 0.0 0.0   Cash and cash equivalent   6.9 5.8 0.9 0.9 0.9 0.9 0.0 0.0   1000.0 Capital use efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   332.3 241.1 -51.1 -72.5 -80.6 -18.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 -29 40 -1 45 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 -29 42 4 52 0 0   EBIT / employee   0 0 -29 40 -1 45 0 0   Net earnings / employee   0 0 -16 18 -4 9 0 0